K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTSee what precise nutrition can do.Get to the bottom of tough gastrointestinal cases and recommend diets precisely designed to meet your patients' unique needs. + Find out more